Question 1

Does Ubs own CGON stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 977,695 shares of CGON (CG Oncology), worth $69.5M.

Question 2

How many shares of CGON does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 977,695 shares of CGON (CG Oncology).

Question 3

What is Ubs' CGON position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' CGON position is worth $69.5M.

Question 4

Is Ubs buying or selling CGON?

Accepted Answer

In Q2 2026, Ubs reduced its CGON position by 334,283 shares (-25.5%).

Question 5

When did Ubs first buy CGON?

Accepted Answer

Ubs already held CGON in its Q1 2024 13F, the earliest on record, and has listed it in 10 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	977,695	-25.5%	$69.5M	0.0%	$71.05	0
2026-Q1	Decreased	1.3M	-31.8%	$88.8M	0.0%	$60.55	0
2025-Q4	Decreased	1.9M	-9.5%	$79.9M	0.0%	$40.17	0
2025-Q3	Decreased	2.1M	-4.6%	$85.6M	0.0%	$39.08	0
2025-Q2	Increased	2.2M	+30.8%	$58M	0.0%	$25.95	37
2025-Q1	Increased	1.7M	+68.1%	$41.7M	0.0%	$26.42	43
2024-Q4	Increased	1M	+1071.7%	$29.1M	0.0%	$28.50	46
2024-Q3	Increased	86,534	+10.8%	$3.3M	0.0%	$37.87	29
2024-Q2	Increased	78,080	+234.8%	$2.5M	0.0%	$31.57	42
2024-Q1	New	23,323	-	$1M	0.0%	$43.90	35

CGON10 quarters

CGON
10 quarters